认领应用
LifeServe’s patent-pending Cobra Tracheostomy device performs percutaneous tracheostomy (PT) that is simple, safe and effective for use by a broader range physicians than current products. The Cobra is less complex and more ergonomic to satisfy demands for simplified and empowering PT devices that require less experience to master, reduced time per procedure and can be performed at the bedside by a broader array of physicians.Tracheostomy procedures are performed on more than 120,000 U.S. citizens annually, however fewer than 60% are performed using PT, a cost-effective procedure. Broad adoption of bedside PT with the Cobra has a potential annual cost savings of… · More at least $230M in the U.S.
成为钛媒体专业用户,即可查看联系方式
您是否确认要删除该条评论吗?
账号合并
经检测,你是“钛媒体”和“商业价值”的注册用户。现在,我们对两个产品因进行整合,需要您选择一个账号用来登录。无论您选择哪个账号,两个账号的原有信息都会合并在一起。对于给您造成的不便,我们深感歉意。
评论(0)